**Title: More than 16,000 Doses of Ervebo Vaccine Arrive in Ebola-Hit DR Congo**
The Democratic Republic of the Congo (DRC) has received a significant shipment of the Ervebo vaccine, with over 16,000 doses arriving in the capital, Kinshasa, as the country grapples with its deadliest Ebola outbreak to date. This delivery, which includes 16,250 doses, marks the first installment of a total of 70,000 doses that the World Health Organization (WHO) and its partners pledged to provide to the DRC.
The shipment arrived late on Friday evening, following a commitment made by WHO on Thursday to assist the DRC amid a rapidly escalating health crisis. The outbreak has already resulted in more than 2,500 deaths from nearly 5,300 confirmed cases, prompting the United Nations to issue warnings about the exponential spread of the virus.
The current outbreak, which was officially declared in mid-May 2026, is believed to have begun weeks earlier. Health officials are concerned that the transmission rate is still rising, with projections indicating that it could potentially triple from its current levels. The ongoing armed conflict in eastern DRC, delays in case identification, and inadequate healthcare infrastructure have all hindered efforts to control the virus.
While the Ervebo vaccine is approved for use against the Zaire strain of the Ebola virus, the Bundibugyo strain currently circulating in the DRC does not have an approved vaccine or treatment. However, early data from animal trials suggest that Ervebo may provide some level of protection against this strain. Health Minister Samuel Roger Kamba noted that the vaccine has been utilized on a large scale in previous outbreaks, specifically during the 2018 to 2020 Ebola crisis.
Of the total 70,000 doses pledged, 20,000 will be allocated for a late-stage clinical trial aimed at assessing the vaccine's effectiveness against the Bundibugyo strain. The remaining doses are designated for front-line healthcare workers who are at the highest risk of exposure to the virus.
As the DRC continues to face this health emergency, the arrival of the Ervebo vaccine is a critical step in the fight against Ebola. Health officials and international partners are working tirelessly to implement vaccination campaigns and control measures to curb the outbreak's spread and protect vulnerable populations. More doses of the vaccine are expected to arrive in the coming weeks, further bolstering the DRC's response to this ongoing crisis.